Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever

Clinical Infectious Diseases

Volumn 47, Issue 9, 2008, Pages 1188-1196

  Paddock, Christopher D ^a   Finley, Richard W ^d   Wright, Cynthia S ^g   Robinson, Howard N ^h   Schrodt, Barbara J ⁱ   Lane, Carole C ^j   Ekenna, Okechukwu ^f   Blass, Mitchell A ^c   Tamminga, Cynthia L ^k   Ohl, Christopher A ^l   McLellan, Susan L F ^m   Goddard, Jerome ^e   Holman, Robert C ^b   Openshaw, John J ^b   Sumner, John W ^a   Zaki, Sherif R ^a   Eremeeva, Marina E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Saint Joseph's Hospital of Atlanta   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e Mississippi State Department of Health   (United States)

^f Singing River Hospital   (United States)

^g Wright's Family Healthcare   (United States)

^h Bernstein and Robinson Dermatology   (United States)

ⁱ University Associates in Dermatology   (United States)

^j Lane Medical Group   (United States)

^k NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; DOXYCYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PENICILLIN DERIVATIVE;

ADULT; AGED; ANIMAL CELL; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; DELIRIUM; DIARRHEA; FEMALE; GEOMETRY; HEADACHE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; LYMPHADENOPATHY; MALE; MYALGIA; NAUSEA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RICKETTSIA; RICKETTSIA PARKERI; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SEIZURE; SEROLOGY; VESICULAR RASH; VOMITING;

ADULT; AGED; ANIMALS; ANTIBODIES, BACTERIAL; ARACHNID VECTORS; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; FEMALE; HUMANS; IXODIDAE; MALE; MIDDLE AGED; RICKETTSIA; RICKETTSIA INFECTIONS; ROCKY MOUNTAIN SPOTTED FEVER; UNITED STATES;

EID: 53349157171     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592254     Document Type: Article

References (45)

1. Parker RR. Symptomatology and certain other aspects of Rocky Mountain spotted fever. In: Moulton FR, ed. Rickettsial diseases of man. Washington, DC: American Association for the Advancement of Science, 1948:139-46.
2. Parker RR, Kohls GM, Cox GW, Davis GE. Observations on an infectious agent from Amblyomma maculatum. Public Health Rep 1939; 54:1482-4.
3. Goddard J, Norment BR. Notes on the geographical distribution of the Gulf Coast tick, Amblyomma maculatum (Koch) [Acari:Ixodidae]. Entomol News 1983; 94:103-4.
4. Sumner JW, Durden LD, Goddard J, et al. Gulf Coast ticks (Amblyomma maculatum) and Rickettsia parkeri, United States. Emerg Infect Dis 2007; 13:751-3.
5. Parker RR. A pathogenic rickettsia from the Gulf Coast tick, Amblyomma maculatum. New York: Proc Third Int Congr Microbiol, 1940: 390-1.
6. Paddock CD, Sumner JW, Comer JA, et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 2004; 38:805-11.
7. Finley RW, Goddard J, Raoult D, Eremeeva ME, Cox RD, Paddock CD. Rickettsia parkeri: a case of tick-borne, eschar-associated spotted fever in Mississippi [abstract 188]. In: Program and abstracts of the International Conference on Emerging Infectious Diseases 2006 (Atlanta, GA). Washington, DC: American Society for Microbiology, 2006: 110.
8. Whitman TJ, Richards AL, Paddock CD, et al. Rickettsia parkeri infection after tick bite, Virginia. Emerg Infect Dis 2007; 13:334-6.
9. Raoult D, Paddock CD. Rickettsia parkeri and other spotted fevers in the United States. N Engl J Med 2005; 353:626-7.
10. Paddock CD, Koss T, Eremeeva ME, Dasch GE, Zaki SR, Sumner JW. Isolation of Rickettsia akari from eschars of patients with rickettsialpox. Am J Trop Med Hyg 2006; 75:732-8.
11. Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999; 179:1469-76.
12. Eremeeva ME, Bosserman EA, Demma LJ, Zambrano ML, Blau DM, Dasch GA. Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona. Appl Environ Microbiol 2006; 72:5569-77.
13. Swerdlow D, Nicholson W, Anderson A, et al. Revision of the surveillance case definition for Rocky Mountain spotted fever. Available at: http://www.cste.org/PS/2007ps/2007psfinal/ID/07-ID-05.pdf. Accessed 18 September 2008.
14. Hazard GW, Ganz RN, Nevin RW, et al. Rocky Mountain spotted fever in the eastern United States: thirteen cases from the Cape Cod area of Massachusetts. N Engl J Med 1969; 280:57-62.
15. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain spotted fever: a clinical dilemma. Curr Clin Top Infect Dis 1981; 2:89-108.
16. Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever: a clinical review based on 48 confirmed cases. Medicine 1990; 69:35-45.
17. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected vector in Arizona. N Engl J Med 2005; 353:587-94.
18. Greenberg M, Pellitteri O, Klein IF, Huebner RJ. Rickettsialpox - a newly recognized rickettsial disease. II. Clinical observations. J Am Med Assoc 1947; 133:901-6.
19. Rose HM. The clinical manifestations and laboratory diagnosis of rickettsialpox. Ann Intern Med 1949; 31:871-83.
20. Koss T, Carter EL, Grossman ME, et al. Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001. Arch Dermatol 2003; 139:1545-52.
21. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States. MMWR 2006; 55(RR-4):1-27.
22. Harrell GT. Rocky Mountain spotted fever. Medicine 1949; 28:333-70.
23. Wolbach SB. Studies on Rocky Mountain spotted fever. J Med Res 1919; 41:1-139.
24. Zavala-Castro JE, Zavala-Velázquez, Walker DH, et al. Fatal human infection with Rickettsia rickettsii, Yucatán, Mexico. Emerg Infect Dis 2006; 12:672-5.
25. Paddock CD, Fernandez S, Echenique GA, et al. Rocky Mountain spotted fever in Argentina. Am J Trop Med Hyg 2008; 78:687-92.
26. Ramphal R, Kluge R, Cohen V, Feldman R. Rocky Mountain spotted fever and jaundice: two consecutive cases acquired in Florida and a review of the literature on this complication. Arch Intern Med 1978; 138:260-3.
27. Walker DH, Gay RM, Valdes-Dapena M. The occurrence of eschars in Rocky Mountain spotted fever. J Am Acad Dermatol 1981; 4:571-6.
28. Paddock CD, Zaki SR, Koss T, et al. Rickettsialpox in New York City: a persistent urban zoonosis. Ann NY Acad Sci 2003; 990:36-44.
29. Krusell A, Comer JA, Sexton DJ. Rickettsialpox in North Carolina. Emerg Infect Dis 2002; 8:727-8.
30. Graf PCF, Chretien JP, Ung L, Gaydos JC, Richards AL. Prevalence of seropositivity to spotted fever group rickettsiae and Anaplasma phagocytophilum in a large, demographically diverse US sample. Clin Infect Dis 2008; 46:70-7.
31. Marshall GS, Stout GG, Jacobs RF, et al. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 2003; 157:443-8.
32. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005; 18:719-56.
33. de Sousa R, Barata D, Vitorino L, Santos-Silva M, et al. Rickettsia sibirica isolation from a patient and detection in ticks, Portugal. Emerg Infect Dis 2006; 12:1103-8.
34. Bitam I, Parola P, Matsumoto K, et al. First molecular detection of R. conorii, R. aeschlimannii, and R. massiliae in ticks in Algeria. Ann NY Acad Sci 2006; 1078:368-72.
35. Sarih M, Socolovschi C, Boudebouch N, Hassar M, Raoult D, Parola P. Spotted fever group rickettsiae in ticks, Morocco. Emerg Infect Dis 2008; 14:1067-73.
36. Fernández-Soto P, Pérez-Sánchez R, Álamo-Sanz R, Encinas-Grandes A. Spotted fever group rickettsiae in ticks feeding on humans in northwestern Spain: is Rickettsia conorii vanishing? Ann NY Acad Sci 2006; 1078:331-3.
37. Márquez FJ, Rodríguez-Liébana JJ, Soriguer RC, et al. Spotted fever group Rickettsia in brown dog ticks Rhipicephalus sanguineus in southwestern Spain. Parasitol Res 2008; 103:119-22.
38. Paddock CD. Rickettsia parkeri as a paradigm for multiple causes of tick-borne rickettsioses in the Western hemisphere. Ann N Y Acad Sci 2005; 1063:315-26.
39. Wikswo M, Hu R, Dasch GA, et al. Detection and identification of spotted fever group rickettsiae in Dermacentor species from southern California. J Med Entomol 2008; 45:509-16.
40. Apperson CS, Engber B, Nicholson WL, et al. Tick-borne diseases in North Carolina: is "Rickettsia amblyommii" a possible cause of rickettsiosis reported as Rocky Mountain spotted fever? Vector Borne Zoonotic Dis 2008; 8:1-10.
41. Venzal JM, Portillo A, Estrada-Peña A, Castro O, Cabrera PA, Oteo JA. Rickettsia parkeri in Amblyomma triste from Uruguay. Emerg Infect Dis 2004; 10:1493-5.
42. Silveira I, Pacheco RC, Szabó MPJ, Ramos HGC, Labruna MB. Rickettsia parkeri in Brazil. Emerg Infect Dis 2007; 13:1111-3.
43. Nava S, Elshewany Y, Eremeeva ME, Sumner JW, Mastropaolo M, Paddock CD. Rickettsia parkeri in Argentina. Emerg Infect Dis (in press).
44. Conti Díaz IA. Rickettsiosis por Rickettsia conorii (fiebre botonosa del Mediterráneo fiebre de Marsella): estado actual en Uruguay. Rev Med Uruguay 2001; 17:119-24.
45. Seijo A, Picollo M, Nicholson WL, Paddock CD. Fiebre manchada por rickettsias en el Delta del Parana: una enfermedad emergente. Medicina (Buenos Aires). 2007; 67:723-6.